Gene expression profiling of intrahepatic cholangiocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 557-563

  Subrungruang, Ittisak ^a   Thawornkuno, Charin ^a   Porntip, Chawalitchewinkoon Petmitr ^a   Pairojkul, Chawalit ^b,c   Wongkham, Sopit ^c   Petmitr, Songsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Gene expression profile; Intrahepatic cholangiocarcinoma; Metallothione heavy metal pathway.

Indexed keywords

EID: 84877145474     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.557     Document Type: Article

References (42)

1. Arriola E, Rodriguez-Pinilla SM, Lambros MB, et al (2007). Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Res Treat, 106, 181-9.
2. Bay BH, Jin R, Jayasurya A (2001). Analysis of metallothionein expression in human cancers. Acta Histochem Cytochem, 34, 171-6.
3. Bitu CC, Carrera M, Lopes MA, (2012). HOXB7 expression is a prognostic factor for oral squamous cell carcinoma. Histopathology, 60, 662-5.
4. Chee M, Yang R, Hubbell E, et al (1996). Accessing genetic information with high-density DNA arrays. Science, 274, 610-4.
5. Cherian MG, Jayasurya A, Bay BH (2003). Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res, 533, 201-9.
6. Dalkilic I, Schienda J, Thompson TG, Kunkel LM (2006). Loss of FilaminC (FLNC) results in severe defects in myogenesis and myotube structure. Mol Cell Biol, 26, 6522-34.
7. Davenport JW, Fernandes ER, Harris LD, Neale GA, Goorha R (1999). The mouse mitotic checkpoint gene BUB1B, a novel bub1 family member, is expressed in a cell cycle-dependent manner. Genomics, 55, 113-7.
8. Ehehalt F, Rummele P, Kersting S, et al (2011). Hepatocyte nuclear factor (HNF) 4alpha expression distinguishes ampullary cancer subtypes and prognosis after resection. Ann Surg, 254, 302-10.
9. Golub TR, Slonim DK, Tamayo P, et al (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-7.
10. Hamilton SR, Aaltonen LA, International Agency for Research on Cancer., World Health Organization. 2000. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press. 314 p. pp.
11. Hansel DE, Rahman A, Hidalgo M, et al (2003). Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol, 163, 217-29.
12. Haswell-Elkins MR, Satarug S, Tsuda M, et al (1994). Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. Mutat Res, 305, 241-52.
13. Jacob ST, Majumder S, Ghoshal K (2002). Suppression of metallothionein-I/II expression and its probable molecular mechanisms. Environ Health Perspect, 110, 827-30.
14. Jin R, Chow VT, Tan PH, et al (2002). Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis, 23, 81-6.
15. Jinawath N, Chamgramol Y, Furukawa Y, et al (2006). Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology, 44, 1025-38.
16. Kato I, Kuroishi T, Tominaga S (1990). Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan. Jpn J Clin Oncol, 20, 232-7.
17. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005). Cholangiocarcinoma. Lancet, 366, 1303-14.
18. Kim IJ, Kang HC, Park JG (2004). Microarray applications in cancer research. Cancer Res Treat, 36, 207-13.
19. Kurathong S, Lerdverasirikul P, Wongpaitoon V, et al (1985). Opisthorchis viverrini infection and cholangiocarcinoma, A prospective, case-controlled study. Gastroenterology, 89, 151-6
20. Liao WT, Jiang D, Yuan J, et al (2011) HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res, 17, 3569-78.
21. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.
22. McAlpine PJ, Shows TB (1990). Nomenclature for human homeobox genes. Genomics, 7, 460.
23. McLean L, Patel T (2006). Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int, 26, 1047-53.
24. Mosconi S, Beretta GD, Labianca R, et al (2009). Cholangiocarcinoma. Crit Rev Oncol Hematol, 69, 259-70.
25. Nguyen A, Jing Z, Mahoney PS, et al (2000). In vivo gene expression profile analysis of metallothionein in renal cell carcinoma. Cancer Lett, 160, 133-40.
26. Obama K, Ura K, Li M, et al (2005). Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology, 41, 1339-48.
27. Parkin DM, Srivatanakul P, Khlat M, et al (1991). Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer, 48, 323-8.
28. Rizzardi C, Torelli L, Barresi E, et al (2011). BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival. Head Neck, 33, 727-33.
29. Satarug S, Haswell-Elkins MR, Tsuda M, et al (1996). Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis, 17, 1075-81.
30. Schmidt CJ, Jubier MF, Hamer DH (1985). Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. J Biol Chem, 260, 7731-7.
31. Sriamporn S, Pisani P, Pipitgool V, et al (2004). Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health, 9, 588-94.
32. Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56.
33. Stennard FA, Holloway AF, Hamilton J, West AK (1994). Characterisation of six additional human metallothionein genes. Biochim Biophys Acta, 1218, 357-65.
34. Stossel TP, Condeelis J, Cooley L, et al (2001). Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol, 2, 138-45.
35. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC (1997). Increase in primary liver cancer in the UK, 1979-94. Lancet, 350, 1142-3.
36. Thamavit W, Pairojkul C, Tiwawech D, et al (1993). Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis, 14, 2415-7.
37. Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N (1994). Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver. Cancer Lett, 78, 121-5.
38. Ustundag Y, Bayraktar Y (2008). Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol, 14, 6458-66.
39. Vatanasapt V, Uttaravichien T, Mairiang EO, et al (1990). Cholangiocarcinoma in north-east Thailand. Lancet, 335, 116-7.
40. Watt PM, Hickson ID (1994). Structure and function of type II DNA topoisomerases. Biochem J, 303, 681-95.
41. West AK, Stallings R, Hildebrand CE, et al (1990). Human metallothionein genes: structure of the functional locus at 16q13. Genomics, 8, 513-8.
42. West J, Wood H, Logan RF, Quinn M, Aithal GP (2006). Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer, 94, 1751-8.